|

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

RECRUITINGSponsored by Target PharmaSolutions, Inc.
Actively Recruiting
SponsorTarget PharmaSolutions, Inc.
Started2016-07
Est. completion2036-07
Eligibility
Age2 Years+
Healthy vol.Accepted
Locations67 sites
View on ClinicalTrials.gov →

NCT02815891

Summary

TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a research registry of patients with NAFL or NASH within academic and community real-world practices maintained in order to assess the safety and effectiveness of current and future therapies.

Eligibility

Age: 2 Years+Healthy volunteers accepted
Inclusion Criteria:

1\. Adults and children (age 2 or older) being managed or treated for nonalcoholic fatty liver disease. Diagnosis is based on the clinical judgement of the care provider.

Exclusion Criteria:

1\. Inability to provide informed assent/consent.

Conditions3

Liver DiseaseNonalcoholic Fatty LiverNonalcoholic Steatohepatitis

Locations67 sites

Banner University Medical Center - Phoenix Transplant Center and Advanced Liver Clinic
Phoenix, Arizona, 85006
Stanford University
Palo Alto, California, 94304
California Liver Research Institute
Pasadena, California, 91105
University of California, Davis
Sacramento, California, 95817
Silicon Valley Research Institute
San Jose, California, 95128

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.